Researchers at the University of Akron have revealed the evolutionary strength of spider web glue. Published in the May 17, 2010, issue of Nature Communications, the research revealed that the effectiveness and strength of the spider web glue ensues from the highly entangled, cross-linked polymers in each droplet of the glue, which enables the adhesive [...]
¶
Posted 17 May 2010
† P. Driscoll
§
biomaterials § innovation § medtech § surgical glue § surgical sealant § wound management
‡
°
Also tagged: dermabond, fibrin glue, fibrin sealant, hemostasis, market data, medical adhesive, medtech, sealant, surgical glue, surgical sealant, suture, sutures, wound, wound care, wound closure
Below are recent global medical technology market reports from MedMarket Diligence: “Worldwide Drug-Eluting, Bare and Other Coronary Stents Market, 2008-2017.”. See details. “Worldwide Market for Surgical Sealants, Glues, Wound Closure, 2009-2013.” See details. “Ablation Technologies Worldwide Market, 2008-2017:Products, Technologies, Markets, Companies and Opportunities.” See details. bookmark to
The market for surgical closure and securement (sealants, glues, sutures, staples, tapes, hemostasis, anti-adhesion) has entered a phase in which major driving forces are the introduction of new procedures and techniques by the surgical profession, the development by the medical device industry of new wound closure devices and biomaterials, and the growing willingness of surgical [...]
Products for closing and sealing traumatic and surgical wounds, inducing hemostasis, and preventing post-surgical adhesions represent a rapidly growing market with growth in clinical applications, companies and market introductions. MedMarket Diligence has published its 2009 report on "Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2009-2013." The report is described here. The market for [...]
Haemacure Corporation last month disclosed the apparent clinical utility of its fibrin sealant in the prevention of post-surgical adhesion: Haemacure Corporation (TSX : HAE), a Montreal-based specialty bio-therapeutics company developing high-value human plasma-derived protein products for commercialization, disclosed today the positive results of a second preclinical study conducted on the use of its proprietary lead [...]
From MedMarket Diligence report #S145, “Worldwide Surgical Sealants, Glues and Wound Closure Market, 2007-2011.” See link. The use of products such as tapes and sutures for wound closure and securement leads to faster wound healing with less risk of contamination by debris and infectious agents, and with improved cosmetic outcomes. Failure to use these products [...]